glutathione and pulmonary hypertension Pathophysiology of Group 3 Associated with Lung Diseases and/or Hypoxia Strategizing Drug Therapies in Pulmonary
Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes Frontiers Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening The molecular targets of approved treatments for pulmonary arterial hypertension Thorax A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis) ScienceDirect
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



